Pharmacological eEF 2K activation promotes cell death and inhibits cancer progression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacological eEF 2K activation promotes cell death and inhibits cancer progression

Published:2016-08-29 Issue:10 Volume:17 Page:1471-1484
ISSN:1469-221X
Container-title:EMBO reports
language:en
Short-container-title:EMBO Rep

Author:

De Gassart Aude¹,Demaria Olivier²,Panes Rébecca¹,Zaffalon Léa¹,Ryazanov Alexey G³,Gilliet Michel²,Martinon Fabio¹^ORCID

Affiliation:

1. Department of Biochemistry University of Lausanne Epalinges Switzerland

2. Department of Dermatology CHUV Lausanne Switzerland

3. Department of Pharmacology Robert Wood Johnson Medical School Rutgers The State University of New Jersey Piscataway NJ USA

Funder

European Research Council

Human Frontier Science Program

Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung

Publisher

EMBO

Subject

Genetics,Molecular Biology,Biochemistry

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/embr.201642194

Reference48 articles.

1. Drug repositioning: identifying and developing new uses for existing drugs

2. Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines

3. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposiʼs sarcoma

4. Regression of Kaposi’s sarcoma during therapy with HIV-1 protease inhibitors: A prospective pilot study

5. Complete regression of AIDS-related Kaposi‚s sarcoma in a child treated with highly active antiretroviral therapy

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeting eukaryotic elongation factor 2 kinase (eEF2K) with small-molecule inhibitors for cancer therapy;Drug Discovery Today;2024-10

2. Comparing the Malignant Properties of Parental and a knock-in version of HCT116 cell line expressing the CDK2-mutant of eukaryotic Elongation Factor 2 (eEF2);2024-03-25

3. Revealing eEF-2 kinase: recent structural insights into function;Trends in Biochemical Sciences;2024-02

4. Single-nucleus RNA-sequencing reveals novel potential mechanisms of ovarian insufficiency in 45,X Turner Syndrome;2023-12-23

5. mTORC1-selective activation of translation elongation promotes disease progression in chronic lymphocytic leukemia;Leukemia;2023-09-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3